News
The National Pharmacy Association (NPA) has decided against recommending collective action, despite its members unanimously voting to protest unsustainable funding in November.
There’s absolutely no doubt in my mind. The action the NPA has led over the past nine months has changed the game for our network and for our profession.
Superdrug has partnered with PocDoc to introduce an “at-home” cardiovascular disease (CVD) test both online and in-store in over 180 pharmacies across the UK.
Small independent pharmacies are facing a financial hit of thousands of pounds per month after reforms banning NMS subcontracting, C+D has learned.
Boots’ parent company will pay at least $300m to the US government to “resolve allegations” it filled millions of unlawful opioid and controlled substance prescriptions from 2012 to 2023.
New data analysis has revealed the locations of English and Welsh “pharmacy deserts” – the areas worst hit by the more than a thousand pharmacy closures over the last decade.
The Northern Irish pharmacy regulator has confirmed plans to increase annual fees to £477, weeks after the Professional Standards Authority (PSA) “identified weaknesses in multiple [of its] regulatory functions”.
The medicines regulator has upheld a complaint that an article naming UK sources of weight loss drug supply breached advertising regulations banning the promotion of POMs to the public.
Some 25 complaints have been submitted to the Competition and Markets Authority (CMA) arguing that the new pharmacy contract is “anti-competitive”, C+D has learned.
Contractors will reap the benefits of the increased single activity fee (SAF) without having to wait 60 days from the end of April and May, Community Pharmacy England (CPE) has announced.
As all newly qualified pharmacists become independent prescribers from 2026, a pharmacy lecturer shares some of the concerns her students have shared as they complete their studies…
Pfizer has announced it will “discontinue” the development of a weight loss pill amid “potential drug-induced liver injury”, less than two years after it decided “not [to] advance” a previous version.
A retired pharmacist who has recovered from substance misuse has launched the Pharmacy Professionals Recovery Group – a “lifeline” for those suffering with drug or alcohol problems.
The government has issued a warning that multiple strengths of fentanyl delivered through transdermal patches will be out of stock until the end of the year.
The DH has revealed plans to expand the pharmacy RSV vaccine programme by “up to 200 sites in identified target areas” in 2025/26 to “reverse the downward trend” in uptake.
A vet has been suspended for issuing a “false prescription” of tramadol for a dog she “randomly” picked that was actually intended for the treatment of her father.
Following the announcement of the long-awaited pharmacy funding deal, C+D sets out a timeline of when changes are due to be implemented over the course of the next year…
Two pharmacists have received sanctions from the GPhC for failing to “provide assurance” that cannabis based medicinal products (CBMP) were “appropriately prescribed” with “adequate” safeguards in place.
Along with the long-awaited pharmacy funding deal for 2025/26 came several government commitments on what the sector can expect in the future contract – so what exactly has been pledged?
A snowballing number of pharmacists who “feel like they're missing out” are willing to fork out thousands for a Designated Prescribing Practitioner (DPP) to complete their independent prescribing (IP) qualification, C+D has learned.